Innophos Holdings, Inc. Forecasted to Earn FY2019 Earnings of $2.05 Per Share (NASDAQ:IPHS)

Innophos Holdings, Inc. (NASDAQ:IPHS) – Seaport Global Securities decreased their FY2019 EPS estimates for shares of Innophos in a research note issued to investors on Wednesday, November 6th. Seaport Global Securities analyst B. Hundley now forecasts that the specialty chemicals company will earn $2.05 per share for the year, down from their previous estimate of $2.18. Seaport Global Securities also issued estimates for Innophos’ Q4 2019 earnings at $0.59 EPS and FY2020 earnings at $2.39 EPS.

Innophos (NASDAQ:IPHS) last issued its quarterly earnings data on Wednesday, November 6th. The specialty chemicals company reported $0.45 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.10). Innophos had a net margin of 3.79% and a return on equity of 12.35%. The company had revenue of $189.00 million for the quarter, compared to the consensus estimate of $185.55 million. During the same quarter last year, the business posted $0.58 earnings per share. Innophos’s revenue was down 4.1% on a year-over-year basis.

Several other brokerages have also recently weighed in on IPHS. Zacks Investment Research cut Innophos from a “buy” rating to a “hold” rating in a research note on Wednesday, October 30th. ValuEngine cut Innophos from a “hold” rating to a “sell” rating in a research note on Tuesday, October 29th. Finally, BidaskClub cut Innophos from a “buy” rating to a “hold” rating in a research note on Thursday, October 10th. One research analyst has rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average target price of $36.00.

NASDAQ:IPHS traded down $0.09 during trading hours on Friday, hitting $32.04. 421 shares of the company traded hands, compared to its average volume of 293,193. The company has a quick ratio of 1.41, a current ratio of 2.85 and a debt-to-equity ratio of 0.97. The firm’s 50-day simple moving average is $32.60 and its 200-day simple moving average is $29.64. Innophos has a one year low of $22.57 and a one year high of $37.53. The company has a market cap of $640.95 million, a PE ratio of 14.09 and a beta of 1.44.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in IPHS. Versant Capital Management Inc increased its holdings in Innophos by 55.9% in the 3rd quarter. Versant Capital Management Inc now owns 1,037 shares of the specialty chemicals company’s stock worth $33,000 after acquiring an additional 372 shares during the last quarter. Tower Research Capital LLC TRC grew its holdings in Innophos by 471.9% during the 3rd quarter. Tower Research Capital LLC TRC now owns 1,384 shares of the specialty chemicals company’s stock valued at $45,000 after buying an additional 1,142 shares in the last quarter. Meeder Asset Management Inc. grew its holdings in Innophos by 470.0% during the 3rd quarter. Meeder Asset Management Inc. now owns 1,499 shares of the specialty chemicals company’s stock valued at $49,000 after buying an additional 1,236 shares in the last quarter. Bank of Montreal Can grew its holdings in Innophos by 169.7% during the 2nd quarter. Bank of Montreal Can now owns 2,799 shares of the specialty chemicals company’s stock valued at $80,000 after buying an additional 1,761 shares in the last quarter. Finally, Quadrant Capital Group LLC grew its holdings in Innophos by 303.0% during the 3rd quarter. Quadrant Capital Group LLC now owns 3,087 shares of the specialty chemicals company’s stock valued at $98,000 after buying an additional 2,321 shares in the last quarter. Institutional investors own 94.00% of the company’s stock.

Innophos Company Profile

Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.

Recommended Story: Stock Split

Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply